These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24843084)

  • 61. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy-- assessment of a presumed safety-measure procedure.
    Ceulen RP; Jagtman EA; Sommer A; Teule GJ; Schurink GW; Kemerink GJ
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):772-6. PubMed ID: 20926321
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Endovenous laser ablation and foam sclerotherapy for varicose veins: does the presence of perforating vein insufficiency affect the treatment outcome?
    Köroglu M; Eris HN; Aktas AR; Kayan M; Yeşildağ A; Cetin M; Parlak C; Gürses C; Akhan O
    Acta Radiol; 2011 Apr; 52(3):278-84. PubMed ID: 21498363
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer.
    Campos W; Torres IO; da Silva ES; Casella IB; Puech-Leão P
    Ann Vasc Surg; 2015 Aug; 29(6):1128-35. PubMed ID: 26004968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Foam sclerotherapy.
    Alder G; Lees T
    Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
    Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
    Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Endovenous laser ablation and concomitant foam sclerotherapy: experience in 504 patients.
    Yilmaz S; Ceken K; Alparslan A; Durmaz S; Sindel T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1403-7. PubMed ID: 22167308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complications and side-effects of foam sclerotherapy.
    Guex JJ
    Phlebology; 2009 Dec; 24(6):270-4. PubMed ID: 19952383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of published reports of foam sclerotherapy: what do we know conclusively?
    Myers KA; Roberts S
    Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
    Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Foam sclerotherapy: techniques and uses.
    Bunke N; Brown K; Bergan J
    Perspect Vasc Surg Endovasc Ther; 2009 Jun; 21(2):91-3. PubMed ID: 19767405
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study.
    Kahle B; Leng K
    Dermatol Surg; 2004 May; 30(5):723-8; discussion 728. PubMed ID: 15099314
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.
    Wong K; Connor DE; Andrade OC; Parsi K
    Phlebology; 2021 Aug; 36(7):576-587. PubMed ID: 33736561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LIPIODOL reduces the lytic activity of detergent sclerosants
    Gracé J; Connor D; Bester L; Rogan C; Parsi K
    Phlebology; 2021 Dec; 36(10):771-778. PubMed ID: 34039085
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].
    Rabe E; Breu FX; Flessenkämper I; Gerlach H; Guggenbichler S; Kahle B; Murena R; Reich-Schupke S; Schwarz T; Stücker M; Valesky E; Werth S; Pannier F
    Hautarzt; 2021 Jan; 72(1):50-64. PubMed ID: 33151348
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.